The E3/19K protein of human adenovirus type 2 (Ad2) was the first viral protein shown to interfere with antigen presentation. This 25 kDa transmembrane glycoprotein binds to MHC class I molecules in the endoplasmic reticulum (ER), thereby preventing transport of newly synthesized peptide-MHC complexes to the cell surface and consequently T cell recognition.
Introduction
Human adenoviruses (Ads) typically cause acute disease of the eyes, the respiratory tract, and the gastrointestinal tract (Wold and Horwitz, 2007) . It is well known that Ads, in particular members of species C including Ad2 and Ad5, can also establish persistent infections (Fox et al., 1977) . Infections are facilitated by immunomodulatory proteins that counteract or evade the host immune response (Burgert et al., 2002) . Many of these immune evasion proteins are encoded in the early transcription unit 3 (E3) which is dispensable for virus replication in tissue culture cells but is preserved in all human Ads (Burgert et al., 2002; Windheim et al., 2004 ). E3 proteins have been shown to modulate a variety of immune response mechanisms (Burgert and Blusch, 2000; Burgert et al., 2002; Elsing and Burgert, 1998; Lichtenstein et al., 2004; McNees and Gooding, 2002; McSharry et al., 2008) . The most abundant E3 protein of species C Ads, E3/19K, interferes with transport of major histocompatibility (MHC) class I molecules (in human called HLA) and the MHC class I related molecules MICA/B to the cell surface (Burgert and Kvist, 1985; Cox et al., 1991; McSharry et al., 2008) . The latter serve as ligands for the activating receptor NKG2D (Lodoen and Lanier, 2005) . Consequently E3/19K inhibits recognition by both cytotoxic T lymphocytes and natural killer (NK) cells (Andersson et al., 1987; Burgert and Kvist, 1985; Cox et al., 1991; McSharry et al., 2008; Rawle et al., 1989; Tanaka and Tevethia, 1988) . In line with in vitro data, results generated in animal models strongly support an immunomodulatory function of E3 proteins in vivo (Bruder et al., 1997; Ginsberg et al., 1989; von Herrath et al., 1997) .
E3/19K is an intracellular transmembrane glycoprotein (Ahmed et al., 1982; Persson et al., 1980; Wold et al., 1985) . The mature form of Ad2 E3/19K is derived from a precursor of 159 amino acids by cleaving off a 17 amino acid signal sequence. Down-regulation of MHC class I molecules from the cell surface is accomplished by the combined activity of two functional modules in E3/19K, one for recruiting newly synthesized HLA molecules and a second one for localization in the endoplasmic reticulum (ER) (Burgert and Kvist, 1985; Cox et al., 1991; Nilsson et al., 1989) . The ability to localize to the ER has been linked to an ER retrieval signal in the cytoplasmic tail of E3/19K (Jackson et al., 1990; Jackson et al., 1993) .
The association between E3/19K and MHC class I molecules is non-covalent and does neither require N-linked carbohydrates, present at amino acid positions 12 and 61 in Ad2 E3/19K Kornfeld and Wold, 1981) nor its cytoplasmic tail (Cox et al., 1991; Pääbo et al., 1987; Pääbo et al., 1986b) . The transmembrane segment might be necessary for HLA interaction within the cell but is not required in vitro (Gabathuler et al., 1990; Liu et al., 2005; Pääbo et al., 1986b) . Hence, the interaction is primarily mediated by the lumenal portion of E3/19K (Hermiston et al., 1993; Liu et al., 2005; Pääbo et al., 1986b; Sester and Burgert, 1994) which contains two intramolecular disulfide bonds that are absolutely critical for HLA binding (Sester and Burgert 1994) . Using hybrid MHC molecules containing domains from E3/19K-binding and non-binding MHC alleles, the polymorphic peptide binding domains 1 and 2 of MHC molecules have been shown to be critical for complex formation with E3/19K (Beier et al., 1994; Feuerbach et al., 1994; Jefferies and Burgert, 1990) . Site-directed mutagenesis of MHC class I molecules and antibody binding studies suggest that the contact site is formed or influenced by amino acids within the amino-terminal part of the 1-helix and the carboxy-terminal part of the 2-helix at the junction to 3 (Feuerbach et al., 1994; Flomenberg et al., 1994; Liu et al., 2007) . The latter putative attachment site is reminiscent of that defined in HLA-A2 for the CMV protein US2 which also interferes with antigen presentation (Gewurz et al., 2001) . Binding of E3/19K seems to occur early in the MHC class I assembly pathway even before the 1 and 2 domain are properly folded, possibly during interaction of MHC molecules with calnexin (Sester et al., 2000) . However, E3/19K may also retain certain MHC alleles by interfering with TAPmediated peptide loading (Bennett et al., 1999) .
While the sequences of the E3/19K homologous proteins of Ad species B, C, D and E (Burgert et al., 2002; Deryckere and Burgert, 1996) are remarkably diverse, the ability to bind to and to inhibit HLA transport is preserved (Burgert and Blusch, 2000; Burgert et al., 2002; Deryckere and Burgert, 1996; Flomenberg et al., 1992; Pääbo et al., 1986a) . Only 20 of the 139-151 amino acids present in E3/19K homologues of different serotypes are strictly conserved, including four cysteines. We previously showed that these conserved cysteines form two intramolecular disulfide bonds between positions 11/28 and 22/83, respectively, which are absolutely required for functional activity (McSharry et al., 2008; Sester and Burgert, 1994) . In addition, a relatively conserved stretch of amino acids adjacent to the transmembrane segment has been proposed to be important for HLA association, possibly by influencing correct folding of more distal portions of the molecule (Flomenberg et al., 1992) .
Loss of HLA binding in mutant E3/19K molecules with in-frame deletions covering the lumenal domain confirmed its crucial role for HLA binding (Hermiston et al., 1993) , although gross structural changes, e.g. due to lack of disulfide bond formation (Sester and Burgert, 1994) , could not be excluded. Indeed, most of these mutants had lost binding of the conformation-dependent monoclonal antibody (mAb) Tw1.3, indicating extensive structural changes. Thus, more reagents to assess the structural consequences of mutations would be very useful for further functional analysis.
To gain further insight into the structure of E3/19K and to enable controlled mutagenesis studies, we have raised new mAbs directed to its lumenal domain. Their epitopes were identified and found to represent loop regions mostly connecting beta-strands as determined by secondary structure prediction. Differential binding of these mAbs to E3/19K mutants in which conserved amino acids were replaced by serine or alanine revealed the influence of these mutations on structure and folding of the protein.
Material and methods

Construction, expression and purification of His-tagged E3/19K
A truncated form of the Ad2 E3/19K protein containing amino acids 1-108 and a C-terminal histidine tag was produced by PCR-mediated oligonucleotide-directed mutagenesis. The histidine tag was positioned at the C-terminus of the E3/19K construct as this part is normally inserted in the lipid bilayer and does not appear to be directly involved in complex formation with HLA (Cox et al., 1991; Flomenberg et al., 1992; Gabathuler et al., 1990; Pääbo et al., 1986b) . As template for in vitro mutagenesis and for generation of the expression construct, the EcoRI D fragment of the Ad2 genome (2674bp, comprising nucleotides 27372-30046) was used which had been inserted into the EcoRI site of Bluescript II KS- (Sester and Burgert, 1994) . The 5´oligonucleotide contained an NcoI restriction site followed by an ATG start codon and a codon for alanine, the first amino acid of the mature protein omitting the signal sequence (NcoI primer: 5´-GGCGCCATGGCCAAAAAGGTTGAGTT-TAAG-3´). The 3ó ligonucleotide contained the codons for amino acids 104-108, followed by a BglII restriction site which at the same time changed the codon TGT of Cys-109 to AGA for arginine (BglII oligonucleotide: 5´-AGGGAGATCTAAAGGTGCCAG-TGTTCTC-3´). The purified PCR product was digested with NcoI and BglII, and ligated into NcoI/BglII cleaved pQE60 (Qiagen). The pQE expression construct was transfected into E. coli M15 (pREP4).
Transformants were selected with ampicillin and kanamycin and were screened by preparing small-scale expression cultures upon induction with 2 mM IPTG. Bacteria were solubilized in 8M urea, 0.1 M sodium phosphate, 0.01 M Tris/HCl pH8.0, the lysate was cleared by centrifugation and applied on a nickel chelate column, which was washed sequentially with 8 M urea, 0.1 M sodium phosphate, 0.01 M Tris/HCl pH 6.3, and 0.1 M Tris/HCl pH8.0.
Finally, the histidine-tagged protein was eluted with 0.1 M Tris/0.1 M EDTA pH8.0.
Cell lines, culture conditions and virus infection
293 cells stably expressing wild-type E3/19K of Ad2 (293E3-45), cysteine to serine replacement mutants and Ala-22 with an alanine substitution of C22 have been described (Körner et al., 1992; Sester and Burgert, 1994) . Cell lines transfected with mutants E5, P9, T14, K27, I37, K42, W52, G55, Y60, V62, V64, M87, and W96 were constructed by replacing the codon for the respective amino acid by an alanine codon (to be published elsewhere). Culture of A549 (human lung carcinoma, ATCC CCL 185) and 293 cells, transfection and subsequent selection was performed as described (Hilgendorf et al., 2003; Sester and Burgert, 1994) . Infection with Ad2 and Ad5 was carried out as described using an MOI of~50 (Hilgendorf et al., 2003) . Sp2/0-Ag14 myeloma cells (ATCC CRL 1581) and antibody-producing hybridoma cells were cultured in RPMI 1640 containing 10% fetal calf serum, glutamine and antibiotics.
Immunization of mice and production of mAbs
Three C3H and three BALB/c mice were immunized subcutaneously with 25 µg of purified His-E3/19K in complete Freund´s adjuvant and subsequently boosted twice with the same amount of protein in incomplete Freund´s adjuvant. Sera were tested for E3/19K-specific reactivity using an ELISA employing recombinant His-tagged E3/19K as test antigen, and immunoprecipitations of 293E3-45 cell lysates. Only C3H mice were used for further studies.
The last immunization was done three days before fusion of spleen cells with SP2 cells, essentially as described (Köhler and Milstein, 1975 (Cox et al., 1991) .
Antibody inhibition assay
Maxisorp plates (Nunc) adsorbed overnight with purified His-E3/19K as above were incubated with increasing amounts of E3/19K-specific mAbs per well. After washing twice with blocking solution, radiolabelled mAbs were added and incubated for 2 h, followed by another three washes. The amount of bound radioactive mAb was determined by solubilizing the proteins with 10% SDS and counting in a -counter. For labelling of mAbs with 35 Smethionine, 5x10 6 antibody-producing cells were starved for 30 min in methionine-free medium and then incubated with 500 µCi 35 S-methionine (Redivue, GE Healthcare) for 4h.
Cells were pelleted and the labelled antibodies separated from free 35 S-methionine by gel filtration.
Epitope mapping
Epitope mapping using overlapping 13mer peptides encompassing the E3/19K sequence from amino acid 1 to 108 was carried out by Jerini AG, Germany. Briefly, a total of 49 13mer
peptides with an overlap of 11 amino acids were synthesized directly on a cellulose membrane by SPOT synthesis. After blocking, the cellulose-bound peptide library was incubated sequentially with 1 g/ml of mAbs (2, 4 and 12g/ml were used for Tw1.3) and was then washed with T-TBS (31 mM Tris pH8, 170 mM NaCl, 6.4 mM KCL, 0.05% Tween 20). Bound antibodies were electrotransferred onto PVDF membranes (Millipore) by fractionated blotting using a semi-dry blotter. Membranes were probed with the mAbs and bound mAbs were visualized by HRP-conjugated anti-mouse IgG/ECL.
Radioactive labelling of cells, immunoprecipitation and SDS-PAGE
Labelling with 35 S-methionine (Redivue, GE Healthcare), immunoprecipitation, tunicamycin treatment and SDS-PAGE were carried out essentially as described previously (Burgert and Kvist, 1985; . The rabbit anti-E3/19K serum Ctail was raised against the cytoplasmic tail of Ad2 E3/19K (Sester and Burgert, 1994) . For comparison, the mAb Tw1.3 (Cox et al., 1991) which recognizes E3/19K from Ad2 and Ad5 was included. Radioactive proteins were quantified by PhosphorImager (BAS 1000, Fujix) analysis.
Western blot analysis
Immunoprecipitated material was run on 12% SDS-PAGE minigels and blotted on to Hybond ECL nitrocellulose membranes for 1 h at 100V in 25 mM Tris, 192 mM glycine buffer pH8.3 containing 20% (v/v) methanol using the protean system (Bio-Rad). Non-specific binding sites on the membrane were blocked for one hour in ELISA blocking solution. The membrane was then incubated for 2 h with culture supernatants of the respective antibodies diluted in blocking solution. After several washes, the membrane was incubated for another 2 h with peroxidase-conjugated Affipure Fab-fragment (goat anti-mouse IgG H+L chain, Dianova, Germany) diluted 1:4000 in blocking solution. After washing with several changes of blocking solution and one wash in TBS/0.1% Tween, the blot was developed using ECL substrate (GE Healthcare) and subsequently exposed on Hyperfilm ECL autoradiography film.
Bioinformatics
Homologous sequences to Ad2 were retrieved from the results of a BLAST (Altschul et al., 1990 ) similarity search against the UniProt (The_UniProt_Consortium, 2007) database at the EBI BLAST-server and aligned using MUSCLE (Edgar, 2004) . Jpred (Cole et al., 2008) , PSIPRED (Bryson et al., 2005) and the PredictProtein server (Rost et al., 2004) were used to predict the secondary structure of Ad2. For the prediction of transmembrane helices PHDhtm (Rost et al., 1996) and TMHMM (Krogh et al., 2001) were employed. For further structure prediction the full Ad2 sequence and truncated versions lacking the predicted transmembrane helix and/or signal peptide were submitted to the Genesilico fold recognition meta-server (Kurowski and Bujnicki, 2003) .
Results
Monoclonal antibodies raised against recombinant E3/19K specifically recognize E3/19K of Ad2
Spleens of mice immunized with recombinant His-tagged E3/19K were used to produce hybridomas. Hybridoma supernatants were screened by ELISA for reactivity with E3/19K-His (data not shown). Hybridomas testing positive were re-tested after subcloning and three clones (3A9, 3F4, and 10A2) were used for further analysis. The conformation-sensitive mAb Tw1.3 was used as a control (Cox et al., 1991 (Fig. 2) . For mAb Tw1.3 no significant reactivity was detected in this screen (data not shown), consistent with the notion that this antibody recognizes a discontinuous epitope.
Together with the fact that the mAbs were specific for Ad2 E3/19K, these results allowed us to identify the crucial amino acids within each epitope. The 3A9 epitope comprises the sequence FKSEANE in Ad2. As the Ad5 protein with the corresponding sequence FAAEANE is not recognized, amino acids K and S are critical for reactivity. In an analogous manner, the crucial residue of the 3F4 epitope was identified as D in position 41 since the single amino acid difference in position 41 abrogated reactivity to the Ad5 protein (DKIGKY in Ad2 versus NKIGKY in Ad5). The 10A2 epitope encompasses the sequence KVEFKEPACN in Ad2 while the corresponding sequence in Ad5 is KVDFKEPACN.
Therefore, E in position 5 seems critical for 10A2 reactivity. As 10A2 did not bind to Ad2 E3/19K in immunoprecipitation experiments, but recognized the protein on western blots and with higher reactivity after reduction (Fig. 1B) , the epitope appears to be inaccessible unless the molecule is at least partially unfolded. In line with this view, 10A2 can recognize E3/19K mutants with disrupted C11/C28 bridge using flow cytometry in the presence of 0.075% saponin (data not shown).
Monoclonal antibodies differentially recognize cysteine replacement mutants
Ad2 E3/19K contains a total of seven cysteines. Four of these are conserved among Ads and form two disulfide bridges between C11/C28 and C22/C83, respectively. Serine substitution of these cysteines reduced (C22 and C83) or abolished (C11 and C28) Tw1.3 binding.
Binding studies using the additional mAbs with known epitopes and wild-type and mutant
forms of E3/19K should yield important information as to the structure of the wild-type molecule and the structural changes induced by the mutations. Therefore, quantitative immunoprecipitation experiments with mAbs Tw1.3, 3F4 and 3A9 were carried out using cell lines stably expressing wild-type E3/19K (293E3) and E3/19K with individual cysteines mutated to serine or alanine (Ala-22; Fig. 3A -C). Ala-22 was included, because replacement of this amino acid by serine creates an additional site for N-glycosylation (Sester and Burgert, 1994) , as demonstrated by the slower migration of the C22S mutant 22 (Fig. 3B, lanes 5-8) .
The amounts of wild-type and mutant E3/19K precipitated were determined and related to that precipitated with Ctail serum, as previously described (Sester and Burgert, 1994) , the binding of which was unaffected by the mutations. MAb 10A2 proved negative with wild-type E3/19K and all mutants under immunoprecipitation conditions (data not shown). The relative binding of mAbs to the different mutants is expressed as the ratio of radioactivity detected by mAbs versus that by Ctail, with the ratio obtained for wild-type E3/19K set to 1 (Fig. 4) .
As for Tw1.3 (Fig. 4, top) , binding of 3A9 was abrogated in mutants C11 and C28, whereas its binding of C22 and C83 was essentially unaffected. Reactivity of 3A9 to Ala-22, C101, C109 and C122 was slightly reduced (Fig. 4) fold, respectively (Fig. 4) . Although the absolute amount of the C11, C28 and C22 mutants precipitated in this experiment was small (Fig. 3) , the profound relative increase to Ctail suggests that the 3F4 epitope becomes exposed upon unfolding. Precipitation of mutants C101, C109 and C122 by 3F4 was within the same range as binding to wild-type E3/19K (Fig. 4) . The concordant changes in mAb binding for mutant pairs C11 and C28 as well as C22/Ala-22 and C83 corroborate our previous findings that these cysteine pairs form intramolecular disulfide bonds in the native molecule.
Competitive binding of monoclonal antibodies Tw1.3 and 3A9
Due to the similar binding properties of 3A9 and Tw1.3, we tested whether these mAbs compete for binding to E3/19K using a radioactive competition assay (Fig. 5 ). Unlabelled mAb 3F4 was included as negative control. Fig. 5A shows the binding of radioactively labelled mAb Tw1.3 to E3/19K after preincubation with increasing amounts of unlabelled mAbs. As expected, preincubation with unlabelled Tw1.3 led to a drastic reduction of binding by labelled Tw1.3, whereas preincubation with 3F4 did not. Binding of Tw1.3 was also significantly reduced by preincubation with 3A9 (by~30% at the highest 3A9 concentration).
By contrast, binding of radiolabelled 3A9 could only be inhibited by 3A9 itself but neither by 3F4 nor by Tw1.3 (Fig. 5B) . Thus, Tw1.3 binding to a conformational epitope is affected by prior binding of 3A9 to amino acids 15-21 whereas prior Tw1.3 attachment still allows access of 3A9 to its confined epitope. 
Antibody binding is not affected by carbohydrates
Differential binding of mAbs to E3/19K mutants with alanine substitutions of conserved amino acids
Only 20 of the 104 amino acids representing the lumenal domain of Ad2 E3/19K (including C11, C22, C28 and C83) are strictly conserved in E3/19K homologues of species B, C, D and E (Burgert et al., 2002) . These conserved residues are predicted to be important for structure and function of the molecule. To examine their role, we have used alanine-scanning mutagenesis to alter these residues. A selected set of mutant E3/19K molecules was stably expressed in 293 cells to assess the effect of these mutations on E3/19K structure by monitoring binding of mAbs Tw1.3, 3A9 and 3F4 (Fig. 7) . Cell lines expressing wild-type and mutant E3/19K were lysed and E3/19K was immunoprecipitated with the different antibodies and the relative amount of E3/19K was quantified as described before ( Fig. 3 and   4) . Binding of the conformation-dependent mAb Tw1.3 was severely compromised in mutants P9, I37, K42, Y60, V62 and V64. This is likely caused by global structural changes, since we observed a concomitant increase in 3F4 binding in all but the K42 mutant in which the mutated amino acid lies within the 3F4 epitope (Fig. 2) . Mutations of W52 and G55, presumably located in the vicinity of the 3F4 binding site, also triggered a strong increase in 3F4 binding, yet did not significantly alter binding to Tw1.3. In mutant K27, Tw1.3 binding remained unaffected, 3F4 binding was lost and that of 3A9 was markedly decreased (~70%).
Binding of 3A9 to the other mutants was only marginally affected as compared to that of 3F4 and Tw1.3. Therefore, the epitope recognized by 3A9 seems to be similarly exposed in essentially all of these point mutants. Thus, as the Ctail serum, 3A9 may be very useful to control the expression level of these mutants. The complete set of mAbs with their differential binding properties represents a valuable tool to standardize the expression levels of these mutants when examining the functional alterations induced by the individual mutation.
Discussion
Structure-function studies of E3/19K have been hampered by the availability of one single conformation-sensitive mAb, Tw1.3 (Cox et al., 1991) . For example, deletion of 4-12 amino acids within the lumenal domain, which abrogated HLA binding was generally accompanied by a loss of Tw1.3 binding (Hermiston et al., 1993) . To gain further insight into the structure of E3/19K and to allow further functional studies using E3/19K mutants, a panel of Ad2 E3/19K mutants with mutations in conserved amino acids and a set of new mAbs to Ad2 E3/19K were generated. The minimal epitopes of the new mAbs were identified using peptide scanning and their differential binding to the mutant E3/19K molecules was used to characterize conformational changes associated with single amino acid substitutions of conserved residues. Secondary structure predictions revealed that the mAbs bind to loop regions and overall gave further insight into the potential structure of this paradigmatic viral protein (Fig. 8) .
The reactivity of mAb 3A9 is similar to that of mAb Tw1.3 in its efficient recognition of native E3/19K and its dependence on the formation of the disulfide bond between C11 and C28. However, in contrast to Tw1.3 with its conformational epitope, 3A9 is able to bind to a linear sequence and replacement of cysteines at position 22 or 83 did not have any negative effect on recognition ( Fig. 3 and 4) . The peptide scan identified amino acids 15-21 as minimal epitope of 3A9 (Fig. 2) . The~50% reduced binding of 3A9 to mutant T14 might be expected, as this amino acid lies directly adjacent to the minimal 3A9 epitope and alanine substitution leads to elimination of a carbohydrate. Interestingly, reactivity to K27 was also decreased (bỹ 75%). Both mutants retain the ability to bind to Tw1.3 and are functionally active (data not shown), indicating that the disulfide bonds are correctly formed and only local structural changes occur. Thus, amino acid K27 either appears to constitute part of the 3A9 epitope or may be required for its accessibility. One likely explanation is that K27 is brought in close vicinity to the epitope in three dimensional space by formation of the disulfide bridge between C11 and C28 (Fig. 8) as its disruption is associated with the loss of 3A9 reactivity. Consistent with this view, 3A9 can also detect the wild-type protein after denaturation (in Western blots), but reducing conditions drastically diminish its reactivity (data not shown). Alternatively, K27 may influence accessibility of the 3A9 epitope by forming a salt bridge with one of the glutamic acid residues in the epitope. In this case, the lack of recognition of mutants C11 and C28, and reduced binding of T14 and K27 may result from local conformational changes that may mask the epitope. In summary, 3A9 binds to amino acids 15-21, but full reactivity requires a T in position 14 (or a carbohydrate at position 12) and a K in position 27. Thus, although not completely conformation-independent, this antibody is significantly less sensitive to structural changes than Tw1.3 (Fig. 7) . Therefore, 3A9 may be used to detect most E3/19K mutants not recognized by Tw1.3. Thus, the 3F4 epitope seems to be largely inaccessible in the wild-type molecule, yet becomes more exposed in these mutants presumably undergoing at least partial unfolding. Intriguingly, secondary structure prediction (Fig. 8) suggests that the conserved amino acids Y60, V62 and V64 face the interior side of a -strand which supports the notion that mutation of these residues may cause unfolding thereby affect Tw1.3 binding. Mutants W52 and G55 also showed a profound increase in 3F4 binding but were still bound by Tw1.3, arguing for local structural changes and possibly a close contact of the fourth (the 3F4 epitope) and fifth loop (Fig. 8) .
MAb 10A2 recognized peptides containing amino acids 3 to 13 which are predicted to form a non-structured loop. 10A2 neither precipitated wild-type E3/19K nor any of the alanine mutants under immunoprecipitation conditions. We can not exclude the possibility that this is due to a lower binding of 10A2 to protein A. However, 10A2 recognized Ad2 E3/19K in Western blots, with significantly higher efficiency under reducing than non-reducing conditions. Consistent with these data, unfolding of E3/19K by disruption of disulfide bond C11/C28 and to a lesser degree C22/C83 induced reactivity of 10A2 in saponin-treated cells (data not shown). Thus, the epitope appears to be buried inside the native wild-type molecule and may become exposed upon unfolding, particularly upon disruption of the disulfide bonds.
Our data also shed more light on the conformational epitope of mAb Tw1.3. Previous data suggested that amino acids 3-15 and 23-67 in the core flanked by disulfide bond C22/C83 are important for the Tw1.3 epitope (Sester and Burgert, 1994) . Since amino acids 3-13 may not be exposed in the native protein as shown by the lack of 10A2 binding in immunoprecipitation, direct contacts of Tw1.3 with this part of the molecule appear to be restricted to amino acids 14-16. In support of the latter, prior binding of 3A9 to amino acids 15-21 reduced that of Tw1.3 by about 30% (Fig. 5) . If the 3A9 epitope is adjacent to the Nterminal binding site of Tw1.3, steric hindrance by 3A9 could explain this finding. However, alanine substitution of T14 did not affect the efficiency of immunoprecipitation by Tw1.3 (Fig. 7) . Mutations at positions I37 and V64 led to a complete loss of Tw1.3 binding, and mutations at positions P9, I26 (data not shown), K42, Y60, and V62 reduced binding by 45-85%. In these mutants, the disulfide bond between C11 and C28 is preserved as shown by efficient binding of 3A9 (Fig. 7) . We are unable to distinguish whether these amino acids are actual constituents of the Tw1.3 epitope or merely influence the three-dimensional structure to which this antibody binds. The properties of these mAbs are summarised in table 1.
These mAb mapping data were combined with secondary structure predictions and fold recognition (Kurowski and Bujnicki, 2003; Rost and Sander, 1993) (Fig. 8) . All secondary structure prediction programmes used consistently suggested six -strands in the lumenal domain of E3/19K followed by an -helix in close vicinity to the transmembrane segment that as expected is also predicted to fold as an -helix. The -strands in the core domain of E3/19K are connected by short loops (5-9 amino acids). Interestingly, the epitopes of all three mAbs lie within regions that have a high probability of forming loop structures. The Nterminal part (amino acids 3-13) consists of a loop apparently largely buried inside the molecule, which is followed by the first N-linked glycan at N12 and the surface-exposed loop constituting the 3A9 epitope (amino acids 15-21). A less accessible loop between -strands three and four harbours the 3F4 epitope DKIGK. As the 3F4 signal to peptides 17 and 21 is profoundly reduced compared to peptides 18, 19 and 20 (data not shown) the two amino acids (K and Y) flanking the minimal epitope may also contribute to recognition by 3F4. Thus, the 3F4 binding site may comprise the entire loop four. Between F79 and Y93 a relatively conserved stretch of amino acids is predicted to form an -helix that is covalently linked to -strand two via disulfide bond C22-C83, consistent with an earlier proposal that this cluster of conserved amino acids may be important for the folding of more distal parts (Flomenberg et al., 1992) . -strand two forms another disulfide bond to the first loop (C28-C11). No conclusive suggestion can be made as to the relative orientation of the -strands to each other (parallel/anti-parallel) and to the -helix. However, the disulfide spacing suggests a rather compact structure for E3/19K.
The six -strands may form two -pleated sheets exhibiting an immunoglobulin-like fold.
While the location of the cysteines and the disulfide bonds is clearly different to that in immunoglobulin light chains, immunoglobulin-like folds can obviously be created using variable cysteine arrangements, e.g. in the viral immune evasion protein US2 of human cytomegalovirus (Gewurz et al., 2001) . Several other immune evasion proteins without significant sequence homology to immunoglobulins and with unusual disulfide bonds have recently been crystallized (Mans et al., 2007) The name of the mAbs and the isotype is given under (a) and (b), respectively. The minimal epitope in (c) was determined by scanning a corresponding peptide library. The most crucial amino acids in each epitope are indicated in (d, see text for further explanation). For 3A9 and Tw1.3 also the cysteines in position 11 and 28 are absolutely essential. Columns in e-h summarize the results obtained with these mAbs in immunoprecipitation (e), Western blots (f) under nonreducing (nred) and reducing (red) conditions, as well as in FACS (g) and immunofluorescence (IF), differentiating between strong (+++), average (++), low (+) and little/minimal (+/-) or no signal (-) when detecting wild-type E3/19K. Column (h) indicates the ability of the mAb to recognize unfolded or partially unfolded E3/19K mutants. Tw1.3 (Cox et al., 1991) has a discontinuous epitope (disc) with the most critical amino acids (aa) indicated. 
